Home-Based FeNO Monitoring with the Vivatmo me Device Reveals Type 2 Inflammatory Patterns of Patients with Asthma at Different Treatment Steps: The FeNO@Home Study
Abstract Introduction Fractional exhaled nitric oxide (FeNO) is an important type 2 (T2) asthma biomarker. Home-based FeNO monitoring can provide longitudinal data better reflecting the variable nature of T2 inflammation versus single-point data. We sought to compare longitudinal mean FeNO and varia...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Adis, Springer Healthcare
2025-12-01
|
| Col·lecció: | Pulmonary Therapy |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s41030-025-00336-9 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|